Amphastar Pharmaceuticals (AMPH) Change in Inventory (2013 - 2026)

Amphastar Pharmaceuticals has reported Change in Inventory for 14 years, with the latest figure at $9.9 million in Q2 2026.

• On a quarterly basis, Change in Inventory rose 104.92% year-over-year to $9.9 million in Q2 2026; TTM through Jun 2026 was -$11.2 million, a 116.6% decrease from a year earlier, with the FY2025 full-year figure at $21.1 million, down 56.84% from the prior year.
• Change in Inventory was $9.9 million for Q2 2026 at Amphastar Pharmaceuticals, up from -$6.2 million in the prior quarter.
• The five-year high for Change in Inventory was $31.1 million in Q1 2025, with the low at -$9.0 million in Q4 2025.
• Average Change in Inventory over 5 years is $4.8 million, with a median of $4.8 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Change in Inventory slumped 309.27% in 2023, then surged 3829.48% in 2024.
• Over 5 years, Change in Inventory stood at -$1.2 million in 2022, then slumped by 309.27% to -$4.8 million in 2023, then soared by 608.37% to $24.5 million in 2024, then tumbled by 136.82% to -$9.0 million in 2025, then soared by 209.66% to $9.9 million in 2026.
• The last three Change in Inventory figures came in at $9.9 million (Q2 2026), -$6.2 million (Q1 2026), and -$9.0 million (Q4 2025), per Business Quant data.